A pharmacological rationale for improved everolimus dosing in oncology and transplant patients

Author(s):
Heine, R. ter; Erp, N.P. van; Guchelaar, H.J. (0000-0002-7085-1383); Fijter, J.W. de; Reinders, M.E.J. (0000-0001-9543-567X); Herpen, C.M. van; Burger, D.M.; Moes, D.J.A.R. (0000-0003-3219-253X)
Published
2018
Publication type
Article / Letter to editor
cancerdose individualizationeverolimusnonmempopulation pharmacokineticstransplant
Date issued
2018-07-31
Language
English
Is part of
British Journal of Clinical Pharmacology (2018), Vol. 84, no. 7, p. 1575-1586
hdl
1887/75672
doi
10.1111/bcp.13591
URL
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005589/pdf/BCP-84-1575.pdf